Aptar Reports Second Quarter 2020 Results

AptarGroup, Inc. (NYSE:ATR) today reported second quarter results for 2020 and provided an update related to COVID-19 including the Company’s ability to supply essential products for critical industries and continued health and safety measures being implemented across its global facilities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200730006019/en/

Photo: Aptar's Corporate Headquarters in Crystal Lake, IL

Second Quarter 2020 Summary

• Reported sales and core sales decreased 6% primarily due to the negative effects of COVID-19 on the beauty and beverage markets as well as passing on lower resin costs; negative currency effects were offset by contributions coming from acquisitions
• Reported sales growth of 7% and core sales growth of 6% in our Pharma segment was offset by decreases in reported sales and core sales in our Beauty + Home and Food + Beverage segments
• “Thank You Award” costs of $3.6 million (pretax) were included in second quarter reported and adjusted earnings; this one-time Award was granted to employees who made it possible for Aptar to continue to supply critical infrastructure industries during the initial phases of the COVID-19 crisis
• Reported earnings per share totaled $0.63 (a decrease of 44% compared to the prior year)
• Adjusted earnings per share totaled $0.80 (a decrease of 30% compared to the prior year)
• Reported net income totaled $42 million (a decrease of 43% compared to the prior year)
• Adjusted EBITDA totaled $137 million (a decrease of 15% compared to the prior year)
• Cash flow from operations was $228 million in the first half of 2020 (an increase of 3% compared to the prior year)
• Free cash flow was $105 million in the first half of 2020 (an increase of 9% compared to the prior year)
• Declared quarterly dividend of $0.36 per share
• Subsequent to the end of the quarter, Kimberly Y. Chainey joined Aptar as EVP General Counsel and is a member of the Executive Committee

COVID-19 Update

“We are proud to live up to our purpose and responsibility to society. Most of the products and solutions we make at Aptar play an important role in everyday life, maybe now more than ever,” said Stephan Tanda, Aptar President and CEO. “We all have these products in our homes, dispensing the medicines we take, the food we consume, and the beauty, personal care and household products we count on to get us through the day.”

Aptar is an essential supply chain partner, supporting industries such as pharmaceuticals and consumer products in the 20 countries in which we operate. Aptar’s facilities remain open and operating, albeit some at reduced capacity. “Our people have shown extreme perseverance and commitment to deliver our critical solutions to our customers during this time,” stated Tanda. “We are working very closely with our customers and remain flexible to meet their changing needs while maintaining execution capabilities for the upturn. We have received numerous expressions of appreciation from customers, thanking our people for rising to this challenge, and we will continue to do so while we focus on health and safety as our number one priority.”

Aptar continues to take strong health and safety measures across its global operations. The Company is providing masks to all employees working in its facilities and has escalated cleaning and sanitizing procedures. All employees are invited to a regular cadence of COVID-19 Town Hall calls and Aptar has issued a new remote and flexible work arrangement policy to ensure a minimum number of employees working in the office during this time.

Aptar is closely monitoring the changing dynamics around the world as countries continue to reopen their economies. The initial re-openings in many regions resulted in improved demand for some of Aptar’s products toward the end of the second quarter. While there has been positive recovery momentum in many countries, the recent rise in confirmed cases of COVID-19, especially in the U.S., has caused several local governments to reinstitute confinement protocols and this could impact the pace of economic recovery in the U.S. and elsewhere.

Second Quarter Results

For the quarter ended June 30, 2020, reported sales decreased 6% to $699 million compared to $743 million in the prior year. The headwinds from changes in currency rates were completely offset by revenue generated by recent acquisitions and therefore core sales also declined 6%.

Second Quarter Segment Sales Analysis (Change Over Prior Year)
	Beauty + Home	Pharma	Food + Beverage	Total AptarGroup
Core Sales Growth	(13%)	6%	(15%)	(6%)
Acquisitions	4%	2%	0%	3%
Currency Effects (1)	(3%)	(1%)	(2%)	(3%)
Total Reported Sales Growth	(12%)	7%	(17%)	(6%)
(1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Commenting on the quarter, Tanda said, “Our Pharma segment had another strong quarter, which partially offset declines in our Beauty + Home and Food + Beverage segments. Demand for our drug delivery and active packaging solutions rose across a variety of non-COVID-19 applications, further underscoring the long-term stability of our Pharma segment. Although demand increased for sanitizer dispensers, the beauty and the on-the-go beverage markets continued to be under significant pressure due to negative effects of COVID-19. Cost containment efforts contributed to our bottom line but were not enough to offset the negative effects from lower volumes caused by COVID-19.”

In the Pharma segment, sales increased to customers in the injectables, consumer health care and active packaging markets and offset declines in the prescription market, which faced challenging comparisons to the very strong prior year. In the Beauty + Home segment, the significant negative effects of COVID-19 on the beauty market were partially offset by an increase in sales to the personal care market related to hand sanitizers and liquid soaps. As retailers began to reopen in June, sales increased toward the end of the quarter to certain Beauty + Home customers. In the Food + Beverage segment, weak demand for single-serve premium bottled water and on-the-go functional drink products, due to COVID-19, resulted in significant sales declines in the beverage market. Also, lower custom tooling sales and the effects of passing through lower resin prices to customers also impacted the segment’s overall growth.

Aptar reported second quarter earnings per share of $0.63 compared to $1.12 during the same period a year ago. Current year adjusted earnings per share, excluding restructuring expenses and acquisition-related costs, were $0.80 and down 30% from the prior year adjusted earnings per share, including comparable exchange rates, of $1.14. Aptar recorded $3.6 million of pretax expense related to a one-time Thank You Award for our employees who contributed to our ability to supply critical solutions during the initial phases of the COVID-19 pandemic.

Year-to-Date Results

For the six months ended June 30, 2020, reported sales decreased approximately 4% to $1.42 billion from $1.49 billion a year ago. The headwinds from changes in currency rates were completely offset by revenue generated by recent acquisitions and therefore core sales also declined 4%.

Six Months Year-to-Date Segment Sales Analysis (Change Over Prior Year)
	Beauty + Home	Pharma	Food + Beverage	Total AptarGroup
Core Sales Growth	(11%)	6%	(9%)	(4%)
Acquisitions	2%	3%	0%	2%
Currency Effects (1)	(3%)	(1%)	(2%)	(2%)
Total Reported Sales Growth	(12%)	8%	(11%)	(4%)
(1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Tanda commented on the year-to-date results, “Our Pharma segment continued to report strong year-over-year core sales growth. Our Beauty + Home and Food + Beverage segments experienced a more difficult first half of the year primarily due to the impacts of COVID-19, however we saw progressive signs of improvement for Beauty + Home since the low point in April. Beauty + Home was negatively impacted by reduced orders due to lower prestige beauty sales. Food + Beverage experienced a decline due to lower on-the-go beverage and food service sales due to many people dining at home and the passing through of lower resin costs to customers.”

For the six months year-to-date, Aptar’s reported earnings per share were $1.47, and down 29%, compared to $2.08 reported a year ago. Current year adjusted earnings per share, which exclude restructuring costs and acquisition-related expenses, were $1.72 and down 21% from prior year adjusted earnings per share, including comparable exchange rates, of $2.18.

Strong Cash Flow

The Company generated $228 million of cash flow from operations in the first half of the year, an increase of 3% over $221 million in the prior year. The company generated $105 million of free cash flow (cash flow from operations less capital expenditures) for the first half of 2020, an increase of 9% over $96 million in the prior year, primarily due to a focus on working capital management. Tanda commented, “Despite lower net income, we were able to increase cash flow over the prior year. We continue to invest in our business for the long-term and our balance sheet remains strong.”

Outlook

“There is economic uncertainty in some of our markets, driven in part by the recent spike in COVID-19 cases in many regions of the world. We expect to see gradual improvement in the second half of the year although this will be heavily dependent on the pace and breadth of the resumption of travel activity, the reopening of retail stores and general consumer spending confidence,” said Tanda.

Aptar expects earnings per share for the third quarter of 2020, excluding any restructuring expenses and acquisition-related costs, to be in the range of $0.80 to $0.88. This guidance is based on an effective tax rate range of 28% to 30%.

Cash Dividend

As previously announced, the Board declared a quarterly cash dividend of $0.36 per share. The payment date is August 19, 2020, to stockholders of record as of July 29, 2020.

Open Conference Call

There will be a conference call on Friday, July 31, 2020 at 8:00 a.m. Central Time to discuss the Company’s second quarter results for 2020. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

About Aptar

Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active packaging solutions. Aptar uses insights, design, engineering and science to create dosing, dispensing and protective packaging technologies for the world’s leading brands, in turn making a meaningful difference in the lives, looks, health and homes of millions of people around the world. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Aptar is headquartered in Crystal Lake, Illinois and has 14,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Presentation of Non-GAAP Information

This press release refers to certain non-GAAP financial measures, including current year adjusted earnings per share and adjusted EBITDA, which exclude the impact of business transformation charges (restructuring initiatives), acquisition-related expenses and certain purchase accounting adjustments related to acquisitions and investments. Core sales and adjusted earnings per share also neutralize the impact of foreign currency translation effects when comparing current results to the prior year. Non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures provided by other companies. Aptar’s management believes these non-GAAP financial measures provide useful information to our investors because they allow for a better period over period comparison of operating results by removing the impact of items that, in management’s view, do not reflect Aptar’s core operating performance. These non-GAAP financial measures also provide investors with certain information used by Aptar’s management when making financial and operational decisions. Free cash flow is calculated as cash provided by operating activities less capital expenditures. We use free cash flow to measure cash flow generated by operations that is available for dividends, share repurchases, acquisitions and debt repayment. We believe that it is meaningful to investors in evaluating our financial performance and measure our ability to generate cash internally to fund our initiatives. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results but should be read in conjunction with the unaudited condensed consolidated statements of income and other information presented herein. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures is included in the accompanying tables. Our outlook is provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as exchange rates, or reliably predicted because they are not part of the Company's routine activities, such as restructuring and acquisition costs.

This press release contains forward-looking statements, including certain statements set forth under the “Outlook” section of this press release and statements regarding the anticipated impact of the COVID-19 pandemic. Words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: outbreaks of pandemics, including the impact of the COVID-19 pandemic on our global supply chain and our global customers and operations; the successful integration of acquisitions and the achievement of the expected benefits of acquisitions and investments; the impact of tax reform legislation including changes in tax rates and other tax-related events or transactions that could impact our effective tax rate; the execution of the business transformation plan; economic conditions worldwide including potential deflationary or inflationary conditions or economic downturn or uncertainty in regions we rely on for growth as a result of the COVID-19 pandemic or otherwise; political conditions worldwide; significant fluctuations in foreign currency exchange rates; changes in customer and/or consumer spending levels; financial conditions of customers and suppliers; consolidations within our customer or supplier bases; fluctuations in the cost of materials, components and other input costs; the availability of raw materials and components; our ability to successfully implement facility expansions and new facility projects; our ability to increase prices, contain costs and improve productivity; changes in capital availability or cost, including interest rate fluctuations; volatility of global credit markets; cybersecurity threats that could impact our networks and reporting systems; fiscal and monetary policies and other regulations; direct or indirect consequences of acts of war or terrorism; and work stoppages due to labor disputes. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

AptarGroup, Inc.
Condensed Consolidated Financial Statements (Unaudited)
(In Thousands, Except Per Share Data)
Consolidated Statements of Income
		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2020				2019				2020				2019
Net Sales		$	699,305			$	742,661			$	1,420,858			$	1,487,121
Cost of Sales (exclusive of depreciation and amortization shown below)			441,702				469,441				892,958				938,573
Selling, Research & Development and Administrative			123,365				113,752				249,557				234,967
Depreciation and Amortization			56,429				47,867				107,235				95,356
Restructuring Initiatives			7,331				1,737				12,170				11,267
Operating Income			70,478				109,864				158,938				206,958
Other Income/(Expense):
Interest Expense			(8,734	)			(8,756	)			(17,122	)			(17,970	)
Interest Income			175				1,033				350				2,781
Equity in Results of Affiliates			(328	)			9				(1,127	)			(86	)
Miscellaneous, net			(923	)			(49	)			(2,335	)			417
Income before Income Taxes			60,668				102,101				138,704				192,100
Provision for Income Taxes			18,808				28,180				41,594				55,180
Net Income		$	41,860			$	73,921			$	97,110			$	136,920
Net Income Attributable to Noncontrolling Interests			(21	)			(6	)			(18	)			(1	)
Net Income Attributable to AptarGroup, Inc.		$	41,839			$	73,915			$	97,092			$	136,919
Net Income Attributable to AptarGroup, Inc. per Common Share:
Basic		$	0.65			$	1.16			$	1.51			$	2.17
Diluted		$	0.63			$	1.12			$	1.47			$	2.08
Average Numbers of Shares Outstanding:
Basic			64,262				63,471				64,135				63,219
Diluted			66,384				66,232				66,246				65,842

AptarGroup, Inc.
Condensed Consolidated Financial Statements (Unaudited)
(continued)
($ In Thousands)
Consolidated Balance Sheets
		June 30, 2020			December 31, 2019
ASSETS
Cash and Equivalents		$	247,656		$	241,970
Receivables, net			575,655			558,428
Inventories			381,939			375,795
Other Current Assets			138,321			115,048
Total Current Assets			1,343,571			1,291,241
Net Property, Plant and Equipment			1,097,920			1,087,678
Goodwill			861,928			763,461
Other Assets			510,597			419,739
Total Assets		$	3,814,016		$	3,562,119
LIABILITIES AND EQUITY
Short-Term Obligations		$	217,079		$	110,247
Accounts Payable, Accrued and Other Liabilities			612,688			573,028
Total Current Liabilities			829,767			683,275
Long-Term Obligations			1,082,742			1,085,453
Deferred Liabilities			255,521			221,139
Total Liabilities			2,168,030			1,989,867
AptarGroup, Inc. Stockholders' Equity			1,645,631			1,571,916
Noncontrolling Interests in Subsidiaries			355			336
Total Equity			1,645,986			1,572,252
Total Liabilities and Equity		$	3,814,016		$	3,562,119

AptarGroup, Inc.
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)
($ In Thousands)
		Three Months Ended
		June 30, 2020
		Consolidated				Beauty + Home				Pharma				Food + Beverage				Corporate & Other				Net Interest
Net Sales		$	699,305				299,786				301,259				98,260				-				-
Reported net income		$	41,860
Reported income taxes			18,808
Reported income before income taxes			60,668				(12,755	)			85,467				8,519				(12,004	)			(8,559	)
Adjustments:
Restructuring initiatives			7,331				7,324				(111	)			75				43
Transaction costs related to acquisitions			3,207				3,207
Purchase accounting adjustments related to acquisitions and investments			3,252				2,959				293
Adjusted earnings before income taxes			74,458				735				85,649				8,594				(11,961	)			(8,559	)
Interest expense			8,734																				8,734
Interest income			(175	)																			(175	)
Adjusted earnings before net interest and taxes (Adjusted EBIT)			83,017				735				85,649				8,594				(11,961	)			-
Depreciation and amortization			56,429				25,939				18,617				9,191				2,682				-
Purchase accounting adjustments included in Depreciation and amortization above			(2,867	)			(2,700	)			(167	)
Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)		$	136,579			$	23,974			$	104,099			$	17,785			$	(9,279	)		$	-
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)			19.5	%			8.0	%			34.6	%			18.1	%
		Three Months Ended
		June 30, 2019
		Consolidated				Beauty + Home				Pharma				Food + Beverage				Corporate & Other				Net Interest
Net Sales		$	742,661				342,080				281,939				118,642				-				-
Reported net income		$	73,921
Reported income taxes			28,180
Reported income before income taxes			102,101				26,813				84,425				12,195				(13,609	)			(7,723	)
Adjustments:
Restructuring initiatives			1,737				1,259				(113	)			112				479
Transaction costs related to acquisitions			1,059								1,059
Purchase accounting adjustments related to acquisitions and investments			222								222
Adjusted earnings before income taxes			105,119				28,072				85,593				12,307				(13,130	)			(7,723	)
Interest expense			8,756																				8,756
Interest income			(1,033	)																			(1,033	)
Adjusted earnings before net interest and taxes (Adjusted EBIT)			112,842				28,072				85,593				12,307				(13,130	)			-
Depreciation and amortization			47,867				20,673				16,057				8,637				2,500				-
Purchase accounting adjustments included in Depreciation and amortization above			(222	)							(222	)
Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)		$	160,487			$	48,745			$	101,428			$	20,944			$	(10,630	)		$	-
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)			21.6	%			14.2	%			36.0	%			17.7	%

AptarGroup, Inc.
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)
($ In Thousands)
		Six Months Ended
		June 30, 2020
		Consolidated				Beauty + Home				Pharma				Food + Beverage				Corporate & Other				Net Interest
Net Sales		$	1,420,858				624,346				598,455				198,057				-				-
Reported net income		$	97,110
Reported income taxes			41,594
Reported income before income taxes			138,704				(5,647	)			175,321				14,481				(28,679	)			(16,772	)
Adjustments:
Restructuring initiatives			12,170				12,231				(142	)			178				(97	)
Transaction costs related to acquisitions			4,591				4,591
Purchase accounting adjustments related to acquisitions and investments			4,642				3,221				1,421
Adjusted earnings before income taxes			160,107				14,396				176,600				14,659				(28,776	)			(16,772	)
Interest expense			17,122																				17,122
Interest income			(350	)																			(350	)
Adjusted earnings before net interest and taxes (Adjusted EBIT)			176,879				14,396				176,600				14,659				(28,776	)			-
Depreciation and amortization			107,235				46,525				36,508				18,533				5,669				-
Purchase accounting adjustments included in Depreciation and amortization above			(3,367	)			(2,700	)			(667	)
Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)		$	280,747			$	58,221			$	212,441			$	33,192			$	(23,107	)		$	-
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)			19.8	%			9.3	%			35.5	%			16.8	%
		Six Months Ended
		June 30, 2019
		Consolidated				Beauty + Home				Pharma				Food + Beverage				Corporate & Other				Net Interest
Net Sales		$	1,487,121				709,739				554,640				222,742				-				-
Reported net income		$	136,920
Reported income taxes			55,180
Reported income before income taxes			192,100				50,994				165,683				19,911				(29,299	)			(15,189	)
Adjustments:
Restructuring initiatives			11,267				9,528				213				622				904
Transaction costs related to acquisitions			1,059								1,059
Purchase accounting adjustments related to acquisitions and investments			222								222
Adjusted earnings before income taxes			204,648				60,522				167,177				20,533				(28,395	)			(15,189	)
Interest expense			17,970																				17,970
Interest income			(2,781	)																			(2,781	)
Adjusted earnings before net interest and taxes (Adjusted EBIT)			219,837				60,522				167,177				20,533				(28,395	)			-
Depreciation and amortization			95,356				41,414				31,830				17,102				5,010				-
Purchase accounting adjustments included in Depreciation and amortization above			(222	)							(222	)
Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)		$	314,971			$	101,936			$	198,785			$	37,635			$	(23,385	)		$	-
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)			21.2	%			14.4	%			35.8	%			16.9	%

AptarGroup, Inc.
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
(In Thousands, Except Per Share Data)
		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2020				2019				2020				2019
Income before Income Taxes		$	60,668			$	102,101			$	138,704			$	192,100
Adjustments:
Restructuring initiatives			7,331				1,737				12,170				11,267
Transaction costs related to acquisitions			3,207				1,059				4,591				1,059
Purchase accounting adjustments related to acquisitions and investments			3,252				222				4,642				222
Foreign currency effects (1)							(1,136	)							(3,348	)
Adjusted Earnings before Income Taxes		$	74,458			$	103,983			$	160,107			$	201,300
Provision for Income Taxes		$	18,808			$	28,180			$	41,594			$	55,180
Adjustments:
Restructuring initiatives			1,503				488				2,702				3,166
Transaction costs related to acquisitions			481				53				689				53
Purchase accounting adjustments related to acquisitions and investments			727				42				1,026				42
Foreign currency effects (1)							(314	)							(962	)
Adjusted Provision for Income Taxes		$	21,519			$	28,449			$	46,011			$	57,479
Net Income Attributable to Noncontrolling Interests		$	(21	)		$	(6	)		$	(18	)		$	(1	)
Net Income Attributable to AptarGroup, Inc.		$	41,839			$	73,915			$	97,092			$	136,919
Adjustments:
Restructuring initiatives			5,828				1,249				9,468				8,101
Transaction costs related to acquisitions			2,726				1,006				3,902				1,006
Purchase accounting adjustments related to acquisitions and investments			2,525				180				3,616				180
Foreign currency effects (1)							(822	)							(2,386	)
Adjusted Net Income Attributable to AptarGroup, Inc.		$	52,918			$	75,528			$	114,078			$	143,820
Average Number of Diluted Shares Outstanding			66,384				66,232				66,246				65,842
Net Income Attributable to AptarGroup, Inc. Per Diluted Share		$	0.63			$	1.12			$	1.47			$	2.08
Adjustments:
Restructuring initiatives			0.09				0.02				0.14				0.12
Transaction costs related to acquisitions			0.04				0.01				0.06				0.02
Purchase accounting adjustments related to acquisitions and investments			0.04				-				0.05				-
Foreign currency effects (1)							(0.01	)							(0.04	)
Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share		$	0.80			$	1.14			$	1.72			$	2.18
(1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings and earnings per share using current period foreign currency exchange rates.

AptarGroup, Inc.
Reconciliation of Free Cash Flow to Net Cash Provided by Operations (Unaudited)
(In Thousands)
		Three Months Ended						Six Months Ended
		June 30,						June 30,
		2020			2019			2020			2019
Net Cash Provided by Operations		$	142,653		$	143,504		$	227,686		$	221,140
Less:
Capital Expenditures		$	61,361		$	73,032		$	122,986		$	124,774
Free Cash Flow		$	81,292		$	70,472		$	104,700		$	96,366

AptarGroup, Inc.
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
(In Thousands, Except Per Share Data)
	Three Months Ending
	September 30,
	Expected 2020		2019
Income before Income Taxes		$	82,273
Adjustments:
Restructuring initiatives			6,019
Transaction costs related to acquisitions			708
Purchase accounting adjustments related to acquisitions and investments			647
Foreign currency effects (1)			2,225
Adjusted Earnings before Income Taxes		$	91,872
Provision for Income Taxes		$	25,504
Adjustments:
Restructuring initiatives			1,691
Transaction costs related to acquisitions			101
Purchase accounting adjustments related to acquisitions and investments			123
Foreign currency effects (1)			690
Adjusted Provision for Income Taxes		$	28,109
Net Income Attributable to Noncontrolling Interests		$	(19	)
Net Income Attributable to AptarGroup, Inc.		$	56,750
Adjustments:
Restructuring initiatives			4,328
Transaction costs related to acquisitions			607
Purchase accounting adjustments related to acquisitions and investments			524
Foreign currency effects (1)			1,535
Adjusted Net Income Attributable to AptarGroup, Inc.		$	63,744
Average Number of Diluted Shares Outstanding			66,702
Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2)		$	0.85
Adjustments:
Restructuring initiatives			0.06
Transaction costs related to acquisitions			0.01
Purchase accounting adjustments related to acquisitions and investments			0.01
Foreign currency effects (1)			0.02
Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2)	$0.80 - $0.88	$	0.95
(1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings per share using foreign currency exchange rates as of June 30, 2020, with the exception of the euro for which a 1.15 rate was used.
(2) AptarGroup’s expected earnings per share range for the third quarter of 2020 is based on an effective tax rate range of 28% to 30%. This tax rate range compares to our third quarter of 2019 effective tax rate of 31% on reported and adjusted earnings per share.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200730006019/en/